Literature DB >> 33543238

Importance of Adipose Tissue NAD+ Biology in Regulating Metabolic Flexibility.

Michael P Franczyk1, Nathan Qi2, Kelly L Stromsdorfer1, Chengcheng Li1, Shintaro Yamaguchi1,3, Hiroshi Itoh3, Mihoko Yoshino1, Yo Sasaki4, Rita T Brookheart1, Brian N Finck1, Brian J DeBosch5,6, Samuel Klein1, Jun Yoshino1,7.   

Abstract

Nicotinamide adenine dinucleotide (NAD+) is an essential coenzyme that regulates cellular energy metabolism in many cell types. The major purpose of the present study was to test the hypothesis that NAD+ in white adipose tissue (WAT) is a regulator of whole-body metabolic flexibility in response to changes in insulin sensitivity and with respect to substrate availability and use during feeding and fasting conditions. To this end, we first evaluated the relationship between WAT NAD+ concentration and metabolic flexibility in mice and humans. We found that WAT NAD+ concentration was increased in mice after calorie restriction and exercise, 2 enhancers of metabolic flexibility. Bariatric surgery-induced 20% weight loss increased plasma adiponectin concentration, skeletal muscle insulin sensitivity, and WAT NAD+ concentration in people with obesity. We next analyzed adipocyte-specific nicotinamide phosphoribosyltransferase (Nampt) knockout (ANKO) mice, which have markedly decreased NAD+ concentrations in WAT. ANKO mice oxidized more glucose during the light period and after fasting than control mice. In contrast, the normal postprandial stimulation of glucose oxidation and suppression of fat oxidation were impaired in ANKO mice. Data obtained from RNA-sequencing of WAT suggest that loss of NAMPT increases inflammation, and impairs insulin sensitivity, glucose oxidation, lipolysis, branched-chain amino acid catabolism, and mitochondrial function in WAT, which are features of metabolic inflexibility. These results demonstrate a novel function of WAT NAMPT-mediated NAD+ biosynthesis in regulating whole-body metabolic flexibility, and provide new insights into the role of adipose tissue NAD+ biology in metabolic health.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  NAD+; adiponectin; adipose tissue; insulin sensitivity; metabolic flexibility; obesity

Mesh:

Substances:

Year:  2021        PMID: 33543238      PMCID: PMC7853299          DOI: 10.1210/endocr/bqab006

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  57 in total

Review 1.  Indirect calorimetry: methodological and interpretative problems.

Authors:  D C Simonson; R A DeFronzo
Journal:  Am J Physiol       Date:  1990-03

2.  Metabolic inflexibility: when mitochondrial indecision leads to metabolic gridlock.

Authors:  Deborah M Muoio
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

3.  High-fat diet triggers inflammation-induced cleavage of SIRT1 in adipose tissue to promote metabolic dysfunction.

Authors:  Angeliki Chalkiadaki; Leonard Guarente
Journal:  Cell Metab       Date:  2012-08-08       Impact factor: 27.287

Review 4.  NAD+ homeostasis in health and disease.

Authors:  Mario Romani; Dina Hofer; Elena Katsyuba; Johan Auwerx
Journal:  Nat Metab       Date:  2020-01-20

Review 5.  Interplay between lipids and branched-chain amino acids in development of insulin resistance.

Authors:  Christopher B Newgard
Journal:  Cell Metab       Date:  2012-05-02       Impact factor: 27.287

6.  NAD+-dependent deacetylase SIRT3 in adipocytes is dispensable for maintaining normal adipose tissue mitochondrial function and whole body metabolism.

Authors:  Lane C Porter; Michael P Franczyk; Terri Pietka; Shintaro Yamaguchi; Jonathan B Lin; Yo Sasaki; Eric Verdin; Rajendra S Apte; Jun Yoshino
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-04-10       Impact factor: 4.310

7.  Gastric bypass and banding equally improve insulin sensitivity and β cell function.

Authors:  David Bradley; Caterina Conte; Bettina Mittendorfer; J Christopher Eagon; J Esteban Varela; Elisa Fabbrini; Amalia Gastaldelli; Kari T Chambers; Xiong Su; Adewole Okunade; Bruce W Patterson; Samuel Klein
Journal:  J Clin Invest       Date:  2012-11-26       Impact factor: 14.808

Review 8.  The Pharmacology of CD38/NADase: An Emerging Target in Cancer and Diseases of Aging.

Authors:  Eduardo N Chini; Claudia C S Chini; Jair Machado Espindola Netto; Guilherme C de Oliveira; Wim van Schooten
Journal:  Trends Pharmacol Sci       Date:  2018-02-23       Impact factor: 14.819

9.  CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin.

Authors:  Pierre Cardinal; Caroline André; Carmelo Quarta; Luigi Bellocchio; Samantha Clark; Melissa Elie; Thierry Leste-Lasserre; Marlene Maitre; Delphine Gonzales; Astrid Cannich; Uberto Pagotto; Giovanni Marsicano; Daniela Cota
Journal:  Mol Metab       Date:  2014-08-01       Impact factor: 7.422

10.  Inhibition of Grb14, a negative modulator of insulin signaling, improves glucose homeostasis without causing cardiac dysfunction.

Authors:  Xunshan Ding; Rugmani Iyer; Christopher Novotny; Daniel Metzger; Heather H Zhou; Gordon I Smith; Mihoko Yoshino; Jun Yoshino; Samuel Klein; Gayathri Swaminath; Saswata Talukdar; Yingjiang Zhou
Journal:  Sci Rep       Date:  2020-02-25       Impact factor: 4.379

View more
  2 in total

1.  SIRT1 selectively exerts the metabolic protective effects of hepatocyte nicotinamide phosphoribosyltransferase.

Authors:  Cassandra B Higgins; Allyson L Mayer; Yiming Zhang; Michael Franczyk; Samuel Ballentine; Jun Yoshino; Brian J DeBosch
Journal:  Nat Commun       Date:  2022-02-28       Impact factor: 14.919

2.  The Effect of the Ketogenic Diet on Adiponectin, Omentin and Vaspin in Children with Drug-Resistant Epilepsy.

Authors:  Marcin Chyra; Wojciech Roczniak; Elżbieta Świętochowska; Magdalena Dudzińska; Joanna Oświęcimska
Journal:  Nutrients       Date:  2022-01-22       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.